Inviragan.

• Position: PHARMACEUTICALS AND MEDICAL TECHNOLOGY

Fort Collins

inviragen.com

Emerging infectious diseases, caused by tiny, often vector-borne viruses, are creating a gigantic health crisis across the globe, and Inviragen is poised to make a far-reaching difference.

"Inviragen is focusing on developing vaccines for infectious diseases worldwide," said Dr. Dan Stinchcomb, the company's co-founder and CEO. "Vaccines are the most cost-effective means of improving public health, and the vaccines we are working on serve very significant needs."

Most notably, Inviragen's exclusive license on a dengue vaccine from the Centers for Disease Control and Prevention has led the company to develop DENVax, a vaccine that has shown promise in clinical trials. Mosquito-borne dengue fever threatens 3.6 billion people, or...